Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Trump threatens 50% China tariffs over Iran aid and orders Strait of Hormuz blockade, spiking oil prices and recession ...

The S&P 500 this week closed above both its 50- and 200-day MAs for the first time since late Feb’26. Goldman Sachs is scheduled to report their Q1 ’26 financial results on Monday, April 13.

GE HealthCare's modest growth, margin expansion, and reduced leverage offset recent sluggish share performance. Read more on ...

Cirrus Aircraft delivered 13.1% revenue growth in 2025 to $1.35B, with margin expansion, despite new product launch pressures ...

Diversified hands-off retirement portfolio: 12 funds (ETFs/CEFs/mutual) targeting 6% yield + 6% dividend growth. Read the ...

John Hancock Diversified Macro Fund faced Q4 losses from fixed income and equity positions. Read the full analysis for more ...

Macy's is sporting healthy dividend coverage as it steps up comp sales performance in its core Macy's brand. Read more on the ...

Brightstar Lottery has transformed into a pure-play lottery provider, focusing growth efforts on Italy after divesting ...

U.S. Central Command posted Sunday that it will begin enforcing a maritime blockade on all traffic entering and exiting ...

Southern First Bancshares has demonstrated balance sheet and income statement growth. Read what justifies a Hold rating for ...

Papa John’s (PZZA) buy outlook: international growth, franchise model, solid debt metrics and DDM $39.40 target suggest 10% ...